Impact Biomedical (IBO) Other Working Capital Changes (2022 - 2026)
Impact Biomedical (IBO) posted Other Working Capital Changes of -$47000.0 for Q1 2026, up 25.4% on a QoQ basis from -$63000.0 in Q4 2025, and up 51.55% year-over-year from -$31013.6 in Q1 2025.
Impact Biomedical (IBO) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Impact Biomedical's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$47000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 51.55% year-over-year to -$47000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76000.0 (down 145.78% YoY) and the FY2025 annual result came in at -$126000.0, down 147.55% from the prior year.
- Other Working Capital Changes was -$47000.0 for Q1 2026 at Impact Biomedical, up from -$63000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $323000.0 in Q3 2024 and bottomed at -$136000.0 in Q2 2023.
- A 5-year average of $266.67 and a median of -$1000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes jumped 559.18% — and 2025, when it plunged 4950.0%.
- Impact Biomedical's Other Working Capital Changes stood at $42000.0 in 2022, then sank by 328.57% to -$96000.0 in 2023, then decreased by 4.17% to -$100000.0 in 2024, then surged by 37.0% to -$63000.0 in 2025, then climbed by 25.4% to -$47000.0 in 2026.
- Business Quant data shows IBO's Other Working Capital Changes at -$47000.0 in Q1 2026, -$63000.0 in Q4 2025, and $35000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47,000.00 |
| Mar 31, 2026 | -47,000.00 |
| Mar 31, 2026 | -47,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Sep 30, 2024 | 323,000.00 |
| Sep 30, 2024 | 323,000.00 |